经尿道前列腺等离子电切术治疗高危前列腺增生症

目的探讨经尿道前列腺等离子电切术（PKRP）治疗高危前列腺增生症（BPH）的安全性及疗效。方法回顾分析我院2003年3月至2008年2月接受PKRP治疗的高危BPH患者临床资料，共125例，年龄65．90岁，平均（73．4±5．5）岁：不同程度的排尿困难症状病史6个月～28年。结果本组手术时间25—107（51±24）min，切除前列腺重量16～122（40．6±27．4）g，出血30—126（75．0±25．5）ml，术中无输血、闭孔神经反射、经尿道电切综合征。117例患者随访3～36个月，无真性尿失禁，术后3个月Qmax由术前（7．3±4．2）ml／s升至术后（17．5±3．3）ml／s，IPSS由术前（22．5±5．6）分降至术后（7．1±4．3）分，QOL由术前（4．2±0．9）分降至术后（1．1±0．8）分，RUV由术前（62．5±33．2）ml降至术后（6．9±5．5）ml。结论PKRP是治疗高危BPH患者的安全、有效方法。

Transurethral plasmakinetic resection of prostate for the treament of the aged BPH patients at high risk

Objective To assess the safety and efficacy of transurethral plasmakinetic resection of prostate （PKRP） in treating symptomatic benign prostatic hyperplasia （BPH） in the aged patients at high risk. Methods 125 symptomatic BPH patients at high risk underwent PKRP from March 2003 to February 2008 were reviewed and evaluated.Results The duration of the procedure was 51±24 min （range 25 to 107 min）, the weight of resected prostate glands was 40.6±27.4 g （range 16 to 102 g）. The blood loss was 75.0± 25.5 ml （range 30 to 126 ml）. None required blood transfution, no obturator reflex and transurethral resection syndrome occurred during the operation.117 patients had been followed up for 3 to 36 months, no urinary incontinence occurred after the operation. The peak flow rate increased from 7.3±4.2 to 17.5±3.3 ml/s, the IPSS decreased from 22.5±5.6 to 7.1±4.3, the QOL decreased from 4.2±0.9 to 1.1±0.8 and the RUV decreased from 62.5±33.2 to 6.9±5.5 ml on the 90th postoperative day respectively. Conclusions PKRP is a safe and effective treament for the BPH patients, especially for the aged patients at high risk.